← Back to directory
HV
Hatteras Venture Partners
Durham, North Carolina, United StatesWebsite ↗
Hatteras Venture Partners is a Durham, North Carolina-based venture capital firm founded in 2000, specializing in seed and early-stage investments in human medicine. The firm is dedicated to building transformative companies across biopharmaceuticals, medical devices, diagnostics, and health technology sectors.
Last raised
Aug 2025
1y ago
Latest fund size
$177M
Hatteras Venture Partners VII
AUM
$900M
estimated
Funds raised
Capital this firm has raised, newest first
Hatteras Venture Partners VII
Aug 2025 · HVP VII
$177M
Hatteras Opportunity Fund I
Aug 2025 · HOF I
$30M
Hatteras Venture Partners VI
Jan 2019
$138M
Hatteras Venture Partners V
Jan 2016
—
Hatteras Venture Partners I, LP
Sep 2001
$2.9M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Ladder Health | Seed | — | Jun 2026 | |
| Spolia Therapeutics | — | — | Mar 2026 | |
| Pharaoh Neuro | Series A | $20M | Feb 2026 | |
| PIPr Therapeutics | Growth | — | Nov 2025 | |
| iRiva Medical | — | — | Nov 2025 | |
| Boomerang MedicalLead | Series B | $20M | Sep 2025 | |
| Sensorium Therapeutics | Series A | $25M | Aug 2025 | |
| GeneCentric TherapeuticsLead | Series C | $8M | Jun 2025 |
Sources
Where this data came from